FCM
TVGN icon

FourWorld Capital Management’s Tevogen Bio Holdings TVGN Stock Holding History

FourWorld Capital Management’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-46,400
Closed -$24.8M – 31
2023
Q2 		$24.8M Hold
46,400
– – 4.06% 7
2023
Q1 		$25M Hold
46,400
– – 5.76% 4
2022
Q4 		$23.8M Hold
46,400
– – 32.73% 1
2022
Q3 		$23.5M Hold
46,400
– – 37.32% 1
2022
Q2 		$23.2M Buy
+46,400
New +$23.2M 36.96% 1

Other funds holding TVGN

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
RCM
Robinson Capital Management Grosse Pointe Farms, Michigan $239M AUM 0.62% 1-Year Est. Return

FourWorld Capital Management's TVGN Position: Q3 2023 in Review

FourWorld Capital Management sold out of Tevogen Bio Holdings (TVGN) in Q3 2023, closing a stake of 46,400 shares — an estimated $24.8M sold.

FourWorld Capital Management first reported a position in TVGN in Q2 2022 and held it in 5 quarters. The position peaked at $25M in Q1 2023. 13 funds tracked by Wall St. Rank hold TVGN as of Q3 2023.

  • FourWorld Capital Management reported no remaining Tevogen Bio Holdings position as of Q3 2023 after selling out during the quarter.
  • FourWorld Capital Management sold 46,400 Tevogen Bio Holdings shares in Q3 2023, an estimated $24.8M.
  • FourWorld Capital Management first reported a position in Tevogen Bio Holdings in Q2 2022 and held it in 5 quarters.
  • FourWorld Capital Management's Tevogen Bio Holdings position peaked at $25M in Q1 2023.
  • 13 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q3 2023.

Based on FourWorld Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.